Donna Di Gravio

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors

E. Schmidt, A. Tolcher, M. Sznol, 2017, Clinical Cancer Research.